Skip to content

Participants are given ascorbic acid 2000mg in 100ml 0.9% saline given intravenously by peripheral cannula over 10 minutes. There is no randomisation and follow up is for the duration of the study vis

2 trials

Sponsors

NHS Greater Glasgow and Clyde (UK)

Conditions

Renal Chronic kidney disease, Cardiovascular disease Urological and Genital Diseases Chronic kidney diseaseRenal, Kidney perfusion, Magnetic resonance imaging Urological and Genital Diseases Chronic kidney disease